Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk factors of anti-tuberculosis drug–induced liver injury in Pattaya Bhattamakhun (Banglamung) Hospital
TCTR20250222006Completed
- Sponsor
- N/A
- Start
- Jan 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in Tuberculosis (TB), sponsored by N/A. Primary endpoints: Incidence of anti-tuberculosis drug–induced liver injury and Identification of risk factors for liver injury. Started Jan 2021; status: completed.
02
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on TCTR20250222006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250222006.